Literature DB >> 29213485

Wernicke's encephalopathy with chorea: Neuroimaging findings.

Jivago S Sabatini1, Gustavo Leopold Schutz-Pereira1, Fabrício Feltrin2, Hélio Afonso Ghizone Teive3, Carlos Henrique Ferreira Camargo4.   

Abstract

We present a case report of motor and cognitive disorders in a 36-year-old woman with a history of twelve years of heavy alcohol abuse. The patient presented depressive symptoms over the course of one year after a loss in the family, evolving with ataxia, bradykinesia and choreiform movements. Progressive cognitive decline, sleep alterations and myalgia were also reported during the course of disease evolution. Physical examination revealed spastic paraparesis with fixed flexion of the hips and knees with important pain upon extension of these joints. Initial investigation suggested the diagnosis of thiamine deficiency by brain magnetic resonance imaging (MRI).

Entities:  

Keywords:  Wernicke's encephalopathy; chorea; dementia; movement disorders; thiamine deficiency

Year:  2016        PMID: 29213485      PMCID: PMC5619281          DOI: 10.1590/s1980-5764-2016dn1004020

Source DB:  PubMed          Journal:  Dement Neuropsychol        ISSN: 1980-5764


INTRODUCTION

This case report describes motor and cognitive disorders in a 36-year-old woman with a history of 12 years of alcohol abuse. The patient presented weight loss and depressive symptoms over the course of one year after a loss in the family, evolving with ataxia, nystagmus, bradykinesia, vertigo, choreiform movements of the upper limbs and spastic paraparesis eight months after disease onset. Progressive cognitive decline, sleep alterations and myalgia were also reported during disease evolution. The physical examination revealed spastic paraparesis (fixed flexion of hips and knees, with important pain upon extension of these joints), hyporeflexia and choreic movements in distal arms. Accurate and complete cognitive assessment was difficult due to intense agitation and aggression, as well as speech and language impairments. Initial investigation by brain magnetic resonance imaging (MRI) showed signal hyperintensity in pulvinar thalami (Figure 1). The electroencephalogram (EEG) showed a disorganized pattern with bursts of intermittent slow waves. An electroneuromyography study performed during the hospital stay disclosed severe motor and sensorial axonal polyneuropathy, with signs of ongoing denervation. Unfortunately, serum thiamine measurement was not available. However, taking into account the history of alcohol abuse, the clinical and MRI findings, and the presence of peripheral neuropathy compatible with a dry beriberi pattern, it was decided to administer prompt thiamine replacement. Soon after starting therapy, the patient presented with remarkable regression of motor and cognitive symptoms, including the disappearance of choreiform movements. The patient had a Mini-Mental State Examination (MMSE) score of 23/30 at discharge after 2 weeks, and a score of 28/30 six months after hospitalization. Spastic paresis of the lower limbs persisted, later treated with local injections of botulinum toxin. Despite the improvement of clinical features, five months after discharge a new MRI study showed persistence of hyperintensity on T2 and FLAIR sequences in both medial thalami and pulvinar nuclei. No classical mammillary body hyperintensity was evident after gadolinium injection on the two exams (Figure 2).
Figure 1

[A] Axial FLAIR-weighted MRI images showing signal hyperintensity in the medial and pulvinar regions of both thalami. [B] Sagittal FLAIR-weighted MRI images showing signal hyperintensity in the pulvinar of both thalami.

Figure 2

[A] Coronal T1-weighted postcontrast magnetic resonance image reveals no abnormal enhancement of the mammillary bodies (arrows). [B] Axial fluid-attenuated inversion recovery (FLAIR) image reveals abnormal signal at the periventricular region of both thalamus that persisted after treatment.

[A] Axial FLAIR-weighted MRI images showing signal hyperintensity in the medial and pulvinar regions of both thalami. [B] Sagittal FLAIR-weighted MRI images showing signal hyperintensity in the pulvinar of both thalami. [A] Coronal T1-weighted postcontrast magnetic resonance image reveals no abnormal enhancement of the mammillary bodies (arrows). [B] Axial fluid-attenuated inversion recovery (FLAIR) image reveals abnormal signal at the periventricular region of both thalamus that persisted after treatment. Wernicke's encephalopathy (WE) is a clinical syndrome that results from thiamine (vitamin B1) deficiency. The clinical findings that characterize the syndrome are nystagmus, ophthalmoplegia, mental status changes and cerebellar dysfunction. Uncommon manifestations of the disease at presentation include epileptic seizures, stupor, hypotension, tachycardia, visual disturbances, hearing loss and hallucinations. In later stages, patients may present with choreic dyskinesias, increased muscular tone and spastic paresis, hyperthermia and even coma. MRI is currently considered the best method for confirming diagnosis of this condition and typically shows a bilateral symmetric hypersignal in the paraventricular thalamic nuclei on T2-weighted images.[1,2,3] Other less frequent sites of signal alterations include the mammillary bodies, the tectal plate and, more frequently, the periaqueductal area.[6] Although thalamic hyperintense signal may be found in other diseases (Creutzfeldt-Jakob disease, Fabry's disease, thalamic infarction), the clinical course described in this case strongly suggested thiamine deficiency. Some studies have reported reversion of thalamic hyperintensity after treatment, but this has not occurred in our case to date.[9] EEG may show non-specific slowing of the dominant rhythm at a late stage, proving important in this case to exclude characteristic changes of Creutzfeldt-Jakob disease.[4] Response to thiamine replacement is usually satisfactory, with resolution of ocular symptoms within hours, motor symptoms in days and mental status improvement over the course of weeks. It should be noted that inappropriate treatment or unrecognized WE may evolve to Korsakoff syndrome (KS), resulting in lasting cognitive symptoms, such as anterograde amnesia.[8] "Dry" beriberi is a peripheral manifestation of thiamine deficiency, usually presenting as an axonal motor and sensory polyneuropathy. The symptoms resolve comparatively more slowly than the symptoms of WE, taking from 3 to 6 months to improve after initial thiamine replacement.[7,10,11] There is no consensus with regard to the optimal dose of the therapy, however, it is well established that the disease should be treated using intravenous or intramuscular injections immediately after diagnosis to ensure adequate absorption. This case suggests that faster diagnosis with clinical and MRI features of WE can allow rapid thiamine replacement with good response of severe symptoms such as choreiform movements.
  11 in total

1.  Magnetic resonance imaging as a diagnostic adjunct to Wernicke encephalopathy in the ED.

Authors:  Sung Pil Chung; Seung Whan Kim; In Sool Yoo; Yong Su Lim; Gun Lee
Journal:  Am J Emerg Med       Date:  2003-10       Impact factor: 2.469

2.  EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy.

Authors:  R Galvin; G Bråthen; A Ivashynka; M Hillbom; R Tanasescu; M A Leone
Journal:  Eur J Neurol       Date:  2010-12       Impact factor: 6.089

Review 3.  Do acute lesions of Wernicke's encephalopathy show contrast enhancement? Report of three cases and review of the literature.

Authors:  M Mascalchi; P Simonelli; C Tessa; F Giangaspero; P Petruzzi; L Bosincu; M Conti; G Sechi; F Salvi
Journal:  Neuroradiology       Date:  1999-04       Impact factor: 2.804

4.  Postgastrectomy polyneuropathy with thiamine deficiency.

Authors:  H Koike; K Misu; N Hattori; S Ito; M Ichimura; H Ito; M Hirayama; M Nagamatsu; I Sasaki; G Sobue
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

Review 5.  Wernicke's encephalopathy: new clinical settings and recent advances in diagnosis and management.

Authors:  Gianpietro Sechi; Alessandro Serra
Journal:  Lancet Neurol       Date:  2007-05       Impact factor: 44.182

6.  Polyneuropathy from thiamin deficiency associated with thyrotoxicosis.

Authors:  Panitha Jindahra; Charungthai Dejthevaporn; Surat Komindr; Sriwatana Songchitsomboon; Rawiphan Witoonpanich
Journal:  J Med Assoc Thai       Date:  2005-10

7.  MR imaging findings in 56 patients with Wernicke encephalopathy: nonalcoholics may differ from alcoholics.

Authors:  G Zuccoli; D Santa Cruz; M Bertolini; A Rovira; M Gallucci; C Carollo; N Pipitone
Journal:  AJNR Am J Neuroradiol       Date:  2008-10-22       Impact factor: 3.825

8.  Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy.

Authors:  E Antunez; R Estruch; C Cardenal; J M Nicolas; J Fernandez-Sola; A Urbano-Marquez
Journal:  AJR Am J Roentgenol       Date:  1998-10       Impact factor: 3.959

Review 9.  The evolution and treatment of Korsakoff's syndrome: out of sight, out of mind?

Authors:  A D Thomson; Irene Guerrini; E Jane Marshall
Journal:  Neuropsychol Rev       Date:  2012-05-09       Impact factor: 7.444

10.  "Dry" and "wet" beriberi mimicking critical illness polyneuropathy.

Authors:  S Rama Prakasha; A Sharik Mustafa; Shashidhar Baikunje; K Subramanyam
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

View more
  3 in total

1.  Wernicke Encephalopathy Due to Hyperemesis Gravidarum in Pregnancy: A Case Report.

Authors:  Vikash Talib; Shazia Sultana; Ahmed Hamad; Uzair Yaqoob
Journal:  Cureus       Date:  2018-07-17

2.  A patient with Korsakoff syndrome of psychiatric and alcoholic etiology presenting as DSM-5 mild neurocognitive disorder.

Authors:  Georgios Nikolakaros; Timo Kurki; Arttu Myllymäki; Tuula Ilonen
Journal:  Neuropsychiatr Dis Treat       Date:  2019-05-22       Impact factor: 2.570

Review 3.  Review of Hereditary and Acquired Rare Choreas.

Authors:  Daniel Martinez-Ramirez; Ruth H Walker; Mayela Rodríguez-Violante; Emilia M Gatto
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-08-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.